No Data
No Data
The Three-year Shareholder Returns and Company Earnings Persist Lower as Guangzhou Kingmed Diagnostics Group (SHSE:603882) Stock Falls a Further 9.0% in Past Week
As an investor, mistakes are inevitable. But really big losses can really drag down an overall portfolio. So take a moment to sympathize with the long term shareholders of Guangzhou Kingmed Diagnost
Jinyu Medical (603882): Affected by the external environment and credit impairment, short-term pressure waits for an upward inflection point in profits
Core view: Jinyu Medical announced the 2023 and 2024Q1 results. In '23, the company achieved revenue of 8.540 billion yuan (-44.82%); net profit to mother of 643 million yuan (-76.64%); after deducting non-payment
Jinyu Medical (603882): High base fluctuation routine has resumed
Key investment performance: 2023: revenue of 8.54 billion yuan, YOY -44.8%; net profit to mother of 640 million yuan, YOY -76.6%; net profit after deducting non-return to mother of 360 million yuan, YOY -8
Jinyu Medical (603882) 2023 Annual Report and 2024 Quarterly Report Review: Business Structure Optimization and Rapid Improvement of Testing Programs
Incident: The company announced its 2023 annual report. In 2023, it achieved operating income of 8.540 billion yuan, a year-on-year decrease of 44.82%; realized net profit to mother of 643 million yuan, a year-on-year decrease of 76.64%. The company announced at the same time
Jinyu Medical (603882): Routine medical diagnostic services increased 15%, profitability is expected to recover
Incident: The company released its annual report for the year 20223 and the quarterly report for 2024. In 2023, it achieved operating income of 8.540 billion yuan (yoy -44.82%) and net profit to mother of 643 million yuan (yoy-76.64)
Jinyu Medical (603882): 2023 results are in line with expectations, regular business growth is steady
The 2023 results are in line with market expectations, and the 1Q24 results are lower than market expectations. The company announced 2023 results: revenue of 8.540 billion yuan, down 44.8% year on year, and net profit to mother of 643 million yuan, down 7 percent year on year
No Data